Effects of omecamtiv mecarbil on the contractile properties of skinned porcine left atrial and ventricular muscles
Omecamtiv mecarbil (OM) is a novel inotropic agent for heart failure with systolic dysfunction. OM prolongs the actomyosin attachment duration, which enhances thin filament cooperative activation and accordingly promotes the binding of neighboring myosin to actin. In the present study, we investigat...
Main Authors: | Tomohiro Nakanishi, Kotaro Oyama, Hiroyuki Tanaka, Fuyu Kobirumaki-Shimozawa, Shuya Ishii, Takako Terui, Shin’ichi Ishiwata, Norio Fukuda |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphys.2022.947206/full |
Similar Items
-
Prior Freezing Has Minimal Impact on the Contractile Properties of Permeabilized Human Myocardium
by: Gregory N. Milburn, et al.
Published: (2022-05-01) -
Omecamtiv mecarbil augments cardiomyocyte contractile activity both at resting and systolic Ca2+ levels
by: Arnold Péter Ráduly, et al.
Published: (2023-04-01) -
Subclinical dysfunction of remote myocardium is related to high NT-proBNP and affects global contractility at follow-up, independently of infarct area
by: Giovanni Diana, et al.
Published: (2022-12-01) -
Omecamtiv Mecarbil in the treatment of heart failure: the past, the present, and the future
by: Shujing Zhou, et al.
Published: (2024-03-01) -
Troponin Variants in Congenital Myopathies: How They Affect Skeletal Muscle Mechanics
by: Martijn van de Locht, et al.
Published: (2021-08-01)